Welcome to our dedicated page for ReposiTrak SEC filings (Ticker: TRAK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Searching ReposiTrak’s SEC documents usually means digging through pages on SaaS revenue recognition, marketplace metrics and compliance costs. Our platform starts where EDGAR ends, offering AI-powered summaries that turn the dense text of every ReposiTrak SEC filing into plain English you can act on.
Need the latest ReposiTrak quarterly earnings report 10-Q filing? We post it in real time and pinpoint subscription growth, gross margin and contract liabilities—then answer the questions investors actually ask: “How is scan-based trading performing?” or “What deferred revenue rolled forward?” If you are tracking ReposiTrak insider trading Form 4 transactions, our alerts surface each executive stock move seconds after it hits EDGAR, giving you ReposiTrak Form 4 insider transactions real-time without hunting through PDFs.
For deeper work, explore the ReposiTrak annual report 10-K simplified with section-by-section AI context, or compare proxy data via the ReposiTrak proxy statement executive compensation tag to see how leadership incentives align with SaaS growth. Material developments—new retailer partnerships, marketplace expansions—arrive as ReposiTrak 8-K material events explained so you can react quickly. Our coverage includes every filing type, updated the moment the company reports, and each document comes with concise “why it matters” notes to help you move from data to decision.
- AI summaries clarify key metrics—ARR, churn, GMV
- Real-time feeds for all ReposiTrak SEC filings explained simply
- Side-by-side ReposiTrak earnings report filing analysis across quarters
- Instant alerts on ReposiTrak executive stock transactions Form 4
ReposiTrak (NASDAQ:TRAK) filed a routine Form 4 on 06/25/2025 disclosing CEO/Chair Randall K. Fields’ automatic Rule 10b5-1 sales of 7,500 common shares for about $150k in aggregate, leaving him with roughly 4.8 million shares across direct and indirect holdings. No change to control or overall ownership percentage.
The Form NPORT-P filed for DNP Select Income Fund Inc. is largely a structural template with virtually every quantitative and descriptive field left blank. Sections that normally disclose total assets, liabilities, net assets, portfolio risk metrics, securities-lending details, and monthly performance contain no numeric values or narrative. Likewise, registrant identifiers such as CIK, LEI, and address information are missing. The filing does confirm it is a LIVE electronic submission, but provides no evidence of portfolio holdings or return data for the report period. As a result, the document appears to be an administrative placeholder rather than a substantive disclosure and conveys no material information that would affect an investment assessment of DNP.
ReposiTrak CEO Randall K. Fields reported multiple stock sales executed through a Rule 10b5-1 trading plan via his charitable LLC. The transactions occurred over three consecutive days:
- June 16, 2025: Sold 1,500 shares at avg. price of $20.53
- June 17, 2025: Sold 3,500 shares at avg. price of $20.16
- June 18, 2025: Sold 2,500 shares at avg. price of $20.38
Following these transactions, Fields maintains significant holdings: 3,683,955 shares directly owned and substantial indirect ownership through various entities including 615,260 shares via Riverview Financial Corp. The sales were executed to meet charitable commitments. Fields holds multiple roles as Director, 10% Owner, and CEO. Additionally, he has indirect beneficial ownership of Series B Preferred Stock through Riverview Financial Corp (531,432 shares) and his spouse (12,322 shares).